Local view for "http://purl.org/linkedpolitics/eu/plenary/2010-09-08-Speech-3-099"
| Predicate | Value (sorted: default) |
|---|---|
| rdf:type | |
| dcterms:Date | |
| dcterms:Is Part Of | |
| dcterms:Language | |
| lpv:document identification number |
"en.20100908.5.3-099"2
|
| lpv:hasSubsequent | |
| lpv:speaker | |
| lpv:spoken text |
"Mr President, firstly, I would like to thank all the Members of Parliament who have made interventions. This is very valuable information for us a couple of weeks before what will probably be the ‘end game’ in Tokyo, and we will certainly take it into account.
Before speaking about confidentiality, I will answer a couple of technical questions. One was with respect to the TRIPS agreement on public health, and whether this would be explicitly mentioned in the agreement. It is explicitly referred to, as follows: ‘recognising the principles set out in the Doha Declaration on the TRIPS agreement on public health adopted on 14 November 2001 by the WTO at the Fourth WTO ministerial conference held in Doha, Qatar’.
There were also some questions on privacy. There again, when you look at the text which is currently being discussed, it says ‘nothing in this agreement shall require any party to disclose information (...) which would be contrary to its law or its international agreements, including laws protecting the right of privacy’. Further mention is made in the draft text under discussion to the effect that, with respect to enforcement in digital environments, enforcement procedures shall be implemented in a manner that, ‘consistent with each party’s law, preserves principles relating to freedom of expression, fair process and privacy’. So, explicit mention is made of all this in the agreements.
Let me say a word on medicines. I do not believe that there is a problem with medicines – not only because of ACTA but also because we are currently engaged in discussions with India on this. They have filed a request with the WTO on medicines. We are in discussion with them and I think we will come to a conclusion soon, one that I think will be appreciated by the European Parliament.
I would also add that these kinds of patents are not covered by the chapter on customs in ACTA. There is an explicit reference to the obligatory licensing practice, which is very important in this respect.
Finally, on confidentiality, we have no problem disclosing the texts that we are discussing, but we are not alone. This is a plurinational negotiation, which means that the other parties around the table also have to agree on what will or will not be made public. The explicit question raised was whether you will have the possibility of discussing the eventual agreement before it is signed.
It is not yet clear whether we will reach an agreement, but if we do, we have made sure that we will be in a position to discuss it before signature, as the Commission has obtained this in the negotiation. As you can see, the press release issued at the end of the Washington Round explicitly states that the ‘parties commit to release the text before deciding to sign it’. I think it is difficult to be any more explicit about this.
Thank you very much for your attention."@en1
|
| lpv:unclassifiedMetadata | |
| lpv:videoURI |
Named graphs describing this resource:
The resource appears as object in 2 triples